A3 Adenosine Receptor Agonists for Addiction Relapse Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for addictions and compulsive disorders are ineffective in addressing the underlying neurological changes and relapse issues, as they fail to restore normal brain function in the absence of addictive substances, leading to persistent challenges in managing withdrawal and relapse.
Innovation Solution
Administration of compounds like AST-004, which act as A3R agonists, increase energy metabolism in astrocytes by reversing the loss of glutamate uptake and remodeling the brain reward system, thereby reducing addictive behaviors and withdrawal symptoms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional treatments are used for addiction, then they fail to address underlying neurological changes, but this leads to persistent relapse and withdrawal issues
Solution Approach 1:
The compound AST-004 is administered to prevent relapse before it occurs by restoring normal brain function and reducing cravings in advance, rather than treating relapse after it happens. This proactive approach addresses the underlying neurological changes that drive relapse behavior.
Solution Approach 2:
AST-004 acts as an intermediary substance that mediates between the damaged neurological system and normal function. It binds to A3 adenosine receptors to restore glutamate uptake and dopamine signaling, serving as a bridge to recover normal brain function without requiring the addictive substance.
2Ease of operation
If addictive drugs are used, then they stimulate dopamine release creating rewarding effects, but this leads to permanent functional changes and compulsive behaviors
Solution Approach 1:
Instead of stimulating dopamine release directly like addictive drugs, AST-004 works by enhancing glutamate uptake and indirectly restoring dopamine signaling through A3 receptor activation. This inverted approach achieves rewarding effects through neurorestoration rather than direct dopamine stimulation, avoiding the harmful adaptations caused by chronic drug use.
3Reliability
If withdrawal occurs, then the deficit in reward functioning initiates distress cycle, but this makes breaking free from addiction difficult without restoring normal brain function
Solution Approach 1:
AST-004 enables the brain's own recovery mechanisms to function by restoring glutamate uptake and dopamine signaling. The compound facilitates self-service recovery by allowing astrocytes and neurons to regain normal function, reducing distress and preventing relapse without requiring ongoing external intervention.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
AST-004 significantly reduces cocaine self-administration in mice and shows neuroprotective effects, indicating its potential in treating addictions by enhancing astrocyte function and ATP production, thus addressing the root causes of addictive behaviors.
Implementation Method 1
Administration of compounds like AST-004, which act as A3R agonists, increase energy metabolism in astrocytes
Implementation Method 2
reversing the loss of glutamate uptake
Data Source
AI summary
The present invention relates to adenosine receptor agonist compounds and methods of use thereof for treatment of certain disorders and conditions, for example an addiction or compulsive disorder. Exemplary compounds for use in disclosed methods include:and pharmaceutically acceptable salts thereof.